| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/03/2002 | US6444873 MSH5 ablated mice and uses therefor |
| 09/03/2002 | US6444871 Expression vector for use in the treatment and prevention of viral diseases |
| 09/03/2002 | US6444870 Methods for assessing the role of calcineurin immunosuppression and neurotoxicity |
| 09/03/2002 | US6444806 Complexing |
| 09/03/2002 | US6444805 Recombinant human papillomavirus vaccine expressed in transgenic plants |
| 09/03/2002 | US6444804 Proteins involved in the synthesis and assembly of core lipopolysaccharide of Pseudomonas aeruginosa |
| 09/03/2002 | US6444803 Bone mineralization proteins, DNA, vectors, expression systems |
| 09/03/2002 | US6444802 Human aminopeptidase |
| 09/03/2002 | US6444800 Human gastric cancer antigen gene and gastric cancer antigen protein |
| 09/03/2002 | US6444790 Peptidoglycan recognition proteins |
| 09/03/2002 | US6444789 CD16-II variants |
| 09/03/2002 | US6444787 Vaccines |
| 09/03/2002 | US6444650 Antisense compositions for detecting and inhibiting telomerase reverse transcriptase |
| 09/03/2002 | US6444644 Peptide having specified amino acid sequence; used for inhibition of thromboplastin |
| 09/03/2002 | US6444642 Administering to mammal effective amount of neuregulin polypeptide with p185.sup.erbb2 protein binding activity to stimulate myogenesis of muscle cells |
| 09/03/2002 | US6444470 Genetically transforming zea mays plants, methods involve administering an effective amount of a transformation-enhancing agent to a zea mays plant |
| 09/03/2002 | US6444469 Methods for altering the rate of plant development and plants obtained therefrom |
| 09/03/2002 | US6444468 Treating a sample comprising different double-stranded template polynucleotides wherein said different template polynucleotides contain areas of identity and areas of heterology under conditions which provide for the cleavage of |
| 09/03/2002 | US6444466 Antisense modulation of helicase-moi expression |
| 09/03/2002 | US6444465 Antinsense modulation of Her-1 expression |
| 09/03/2002 | US6444464 Antisense modulation of E2F transcription factor 2 expression |
| 09/03/2002 | US6444456 Human G-coupled protein receptor kinases and polynucleotides encoding the same |
| 09/03/2002 | US6444454 Method for increasing the gene expression of saccharose synthase |
| 09/03/2002 | US6444452 Process for recovering statin compounds from a fermentation broth |
| 09/03/2002 | US6444449 Polynucleotides encoding proteins with d-sorbitol dehydrogenase activity or in vivo, vectors and recombinant organisms which contain such polynucleotides, and methods of making d-sorbitol dehydrogenase and l-sorbose. |
| 09/03/2002 | US6444447 Polymer grafting by polysaccharide synthases |
| 09/03/2002 | US6444446 Calcium binding proteolipid compositions and methods |
| 09/03/2002 | US6444445 Genetic engineering |
| 09/03/2002 | US6444444 Immunogenic composition, comprising at least one nucleic acid fragment as an active component thereof and vector for transformation of a host comprising the nucleic acid fragment |
| 09/03/2002 | US6444443 Gene |
| 09/03/2002 | US6444442 Method of producing a recombinant non-glycosylated gp90 of equine infectious anemia virus (EIAV), and product thereof |
| 09/03/2002 | US6444441 Production of human mutated proteins in human cells by means of homologous recombination |
| 09/03/2002 | US6444439 Cloning and characterization of a cdc15-like adaptor protein (CD2BP1) |
| 09/03/2002 | US6444438 Method for the preparation of a protein by yeasts using an inducible system, vectors and correspondence transformed strains |
| 09/03/2002 | US6444431 Angiostatin receptor |
| 09/03/2002 | US6444429 Gene coding for DNA ligase of hyperthermophilic bacteria Aquifex pyrophilus and protein expressed therefrom |
| 09/03/2002 | US6444426 Normalized dna library from a mixed population of organisms, which comprises: obtaining a dna population from the mixed population of organisms; amplifying the copy number of the dna population so isolated and (ii) recovering a fraction |
| 09/03/2002 | US6444424 Pure thermostable dna polymerase from thermotoga neapolitana (tne). the tne dna polymerase has a molecular weight of about 100 kilodaltons and is more thermostable than taq dna polymerase. the present invention also relates to the cloning |
| 09/03/2002 | US6444422 Analyzing binding activity of oligonucleotides and preferential nucleotide sequences; map biopolymer, monitor sample for molecular weight, classify biopolymer |
| 09/03/2002 | US6444419 Genes to human cancers and its use in the diagnosis and prognosis of human cancer and screening of drugs for cancer |
| 09/03/2002 | US6444321 Reversibly, non-covalent bound surface coating |
| 09/03/2002 | US6444261 A particulate carrier for carrier-bound reactions, detection and/or isolation processes; used for immunoassay markers to bond a solid core by means of biopolymers to an affinity component; particles with usable properties, e.g. marking |
| 09/03/2002 | US6444208 Ribonuclease III from Streptococcus pneumoniae |
| 09/03/2002 | US6444207 Binding with epitope of antigen; anticancer agents |
| 09/03/2002 | US6444206 Sepsis therapy; monoclonal antibodies |
| 09/03/2002 | US6444202 Genetic engineering; immunsuppressants |
| 09/03/2002 | US6444175 Flow cell for synthesis of arrays of DNA probes and the like |
| 09/03/2002 | US6444111 Solid phase synthesis method for the preparation of diverse sequences of separate polymers or nucleic acid sequences using electrochemical placement of monomers of nucleic acids at a specific location on a substrate containing at least one |
| 09/03/2002 | CA2232985C Methods for treating cancers and restenosis with p21 |
| 09/03/2002 | CA2228195C Transgenic insect virus for use as a biopesticide |
| 09/03/2002 | CA2223566C Method for identifying or isolating a molecule and molecules identified thereby |
| 09/03/2002 | CA2160764C Fish pancreatic disease virus |
| 09/03/2002 | CA2154274C Novel genes, polypeptides, and compositions for cold tolerance and drought resistance in plants |
| 09/03/2002 | CA2137809C A genetically engineered cell line for detecting infectious herpes simplex virus and method therefor |
| 09/03/2002 | CA2079778C Inhibitors of thrombin |
| 09/03/2002 | CA2001815C Products and methods for controlling the suppression of the neoplastic phenotype |
| 09/03/2002 | CA1341387C Human manganese superoxide dismutase (hmn-sod) |
| 08/29/2002 | WO2002066993A1 Magnetic isolation and purification of nucleic acids |
| 08/29/2002 | WO2002066952A2 Mass defect labeling for the determination of oligomer sequences |
| 08/29/2002 | WO2002066685A1 Methods and probes for the detection of cancer |
| 08/29/2002 | WO2002066682A2 Rat toxicologically relevant genes and uses thereof |
| 08/29/2002 | WO2002066681A2 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors |
| 08/29/2002 | WO2002066679A1 Intercalator suitable for electrochemical detection of double strand dnas and a process for preparing thereof |
| 08/29/2002 | WO2002066675A2 Methods for detecting mutations |
| 08/29/2002 | WO2002066674A1 A method of identifying differences between nucleic acid molecules |
| 08/29/2002 | WO2002066672A2 Treatment of cns disorders using d-amino acid oxidase and d-aspartate oxidase antagonists |
| 08/29/2002 | WO2002066669A1 Method for purification of soluble ssao |
| 08/29/2002 | WO2002066661A1 Method for producing and transforming clusters of mitochondria |
| 08/29/2002 | WO2002066660A2 Method for identifying herbicidally active substances |
| 08/29/2002 | WO2002066659A1 Method for increasing the oil content in transgenic plants and plant seed |
| 08/29/2002 | WO2002066658A2 Cloning vector comprising a system for direct selection of recombinants |
| 08/29/2002 | WO2002066657A1 Method for the selection of recombinant clones comprising a sequence encoding an antidote protein to a toxic molecule |
| 08/29/2002 | WO2002066656A2 Detection of protein conformation using a split ubiquitin reporter system |
| 08/29/2002 | WO2002066655A1 Novel calcium-independent phospholipases a2, genes thereof and promoter of the same |
| 08/29/2002 | WO2002066653A2 Procaryotic libraries and uses |
| 08/29/2002 | WO2002066652A2 Ehrlichia ruminantium polypeptides, antigens, polynucleotides, and methods of use |
| 08/29/2002 | WO2002066651A2 Nucleotide sequences of the ribosomal protein s12 gene (rpsl) from corynebacterium glutamicum |
| 08/29/2002 | WO2002066650A2 Streptococcus pyogenes polypeptides and corresponding dna fragments |
| 08/29/2002 | WO2002066649A2 ANTI-INTERFERON-α ANTIBODIES |
| 08/29/2002 | WO2002066648A2 Immunoglobulin superfamily variants expressed in mesenchymal cells and therapeutic uses thereof |
| 08/29/2002 | WO2002066647A2 Type 2 ctokine receptor and nucleic acids encoding same |
| 08/29/2002 | WO2002066646A2 Neurotransmission-associated proteins |
| 08/29/2002 | WO2002066645A2 Mutant pro-neurotrophin with improved activity |
| 08/29/2002 | WO2002066644A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 08/29/2002 | WO2002066643A2 Proteins, polynucleotides encoding them and methods of using the same |
| 08/29/2002 | WO2002066642A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 08/29/2002 | WO2002066641A1 Pg-3 and biallelic markers thereof |
| 08/29/2002 | WO2002066640A2 Zinc finger binding domains for nucleotide sequence ann |
| 08/29/2002 | WO2002066639A1 Brain aneurysm-sensitive gene |
| 08/29/2002 | WO2002066638A1 Recombinant gene containing inverted repeat sequence and utilization thereof |
| 08/29/2002 | WO2002066637A2 Method for collecting and using nuclear mrna |
| 08/29/2002 | WO2002066636A2 T cell receptor variants expressed in mesenchymal cells and uses thereof |
| 08/29/2002 | WO2002066635A1 Transgenic animal having drug metabolism enzyme gene and utilization thereof |
| 08/29/2002 | WO2002066632A1 Method of amplifying mrna and cdna in microquantities |
| 08/29/2002 | WO2002066630A1 Methods of modifying eukaryotic cells |
| 08/29/2002 | WO2002066629A2 Recombinant vector containing infectious human cytomegalovirus genome with preserved wild-type characteristics of clinical isolates |
| 08/29/2002 | WO2002066628A2 Supersecretable peptides, processes for their production, and parallel improvement of the secreted form of one or more other polypeptides |
| 08/29/2002 | WO2002066625A1 Novel gene and uses therefor to modify pasture qualities of crops |
| 08/29/2002 | WO2002066624A2 Novel human protease and polynucleotides encoding the same |
| 08/29/2002 | WO2002066623A2 Regulation of human phosphatidic acid-preferring phospholipase a1 |